Skip to main content
Marvel Biosciences Corp. logo

Marvel Biosciences Corp. — Investor Relations & Filings

Ticker · MRVL ISIN · CA57384M1077 TSXV Professional, scientific and technical activities
Filings indexed 255 across all filing types
Latest filing 2021-03-15 Proxy Solicitation & In…
Country CA Canada
Listing TSXV MRVL

About Marvel Biosciences Corp.

https://marvelbiotechnology.com/

Marvel Biosciences Corp. is a pre-clinical stage biotechnology company specializing in the discovery and development of transformative treatments for complex neurological and neurodevelopmental disorders, including Autism Spectrum Disorder, Rett Syndrome, and Fragile X Syndrome. The company's core strategy involves chemical innovation to create synthetic derivatives of existing approved molecules. This drug redevelopment approach leverages established mechanisms to accelerate development and reduce risk. Its lead candidate, MB-204, is a patented synthetic derivative that has demonstrated preclinical efficacy across these target indications and is currently advancing toward first-in-human studies.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for a Special Meeting of Alphanco Venture Corp. It includes instructions for appointing a proxyholder to vote on shareholder resolutions at the meeting. The content focuses on voting procedures and proxy appointment rather than the meeting's results or detailed financial information. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for a meeting.
2021-03-15 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Voting Instruction Form (VIF) for a Special Meeting of Alphanco Venture Corp. scheduled for April 8, 2021. It contains instructions for shareholders on how to vote on specific resolutions related to company policy and escrow agreements. The document is not a report or announcement of financial results, nor is it a regulatory filing or management change announcement. It is a proxy-related document soliciting votes from shareholders for a meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 5192 characters, which is consistent with a detailed proxy solicitation form rather than a brief announcement or a full report.
2021-03-15 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Special Meeting of Shareholders for Alphanco Venture Corp. It details the date, time, location, and agenda of the meeting, including shareholder resolutions to be considered. It includes instructions for voting and proxy submission, and mentions the record date for shareholders entitled to vote. The document is a formal announcement inviting shareholders to attend and vote at the meeting, not the meeting materials themselves or the results of the meeting. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-03-15 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing a special shareholder meeting for Alphanco Venture Corp. to adopt and align with updated TSX Venture Exchange Capital Pool Company (CPC) policies. It discusses shareholder approval for policy changes, amendments to escrow agreements, and an extension of the deadline for a qualifying transaction. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an announcement related to corporate governance and shareholder voting on policy matters, not a full report or financial filing. It is not a proxy solicitation or voting results announcement but rather a meeting announcement and policy update. Given the content and nature, the best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement that does not fit other specific categories.
2021-03-11 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a communication from various Canadian securities commissions regarding Turquoise Hill Resources Ltd. It provides details about the upcoming annual general meeting (AGM), including the date of the meeting, record dates for notice and voting, and information about the distribution of meeting materials to shareholders. The document is short (1869 characters) and serves as an announcement of AGM-related information rather than the AGM materials themselves. It does not contain financial data, management discussion, or detailed reports. Therefore, it fits best as an AGM Information announcement (AGM-R).
2021-02-25 English
News release - English.pdf
Merger & Acquisition Classification · 100% confidence The document is titled 'Arrangement Agreement' dated December 31, 2020, between GameSquare Esports Inc. and Reciprocity Corp. It contains detailed legal and transactional terms such as definitions, covenants, conditions precedent, representations and warranties, and schedules related to a corporate arrangement. The content is consistent with a merger or acquisition agreement rather than a financial report or announcement. There is no indication that this is a proxy statement, voting results, or a regulatory filing announcement. The document is a comprehensive legal contract outlining the terms of a business combination transaction, which fits the category of Merger & Acquisition filings.
2021-01-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.